(Q33821379)
Statements
1 reference
Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia (English)
1 reference
Angela L Hill
1 reference
Bin Sun
1 reference
Jamie L Karagianis
1 reference
Susan B Watson
1 reference
David P McDonnell
1 reference
15 February 2011
1 reference
1 reference
11
1 reference
28
1 reference
15 February 2011
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference